“Very few accelerators have a robust program devoted to medical device startups, so we are filling a huge gap in the life sciences ecosystem,” says Erik M. Halvorsen, PhD, director of the TMC Innovation Institute. “Now we are the only accelerator in the country that runs alternating curriculum tracks on med devices and digital health, which will bolster our efforts to attract top talent in health care innovation.”
Hailing from Texas, New York, and California (among other states) and global counterparts including Mexico, companies accepted into the third TMCx class include:
- Allotrope Medical (Houston) provides precise ureter identification during minimally invasive surgery.
- Bloom Labs (New York) has a credit-card sized rescue inhaler for asthmatics.
- Blumio (San Francisco) is creating a sensor that can measure blood pressure continuously, without the need to rely on the use of an inflatable cuff.
- Briteseed (Chicago) develops smart surgical tools that make surgeons more confident.
- Flexios (Houston) provides streamlined surgical solutions for tendon repair that improve strength, smoothness, and patient satisfaction.
- IntuiTap Medical (Houston) has a handheld device that eliminates the guesswork from spinal taps.
- NovaScan (Milwaukee, Wis) is pioneering an oncology diagnostic platform that provides highly accurate, instantaneous detection of cancer without capital equipment.
- Otricath (Houston) is a catheter system changing the rules in the delivery of liver cancer treatment.
- Voyager Biomedical (College Station, Texas) is creating a better solution for vascular access in dialysis patients.
- WeaRobot (Monterrey, Mexico) is an active exoskeleton for seniors and the physically impaired.
- WestFace Medical (Seattle) puts imaging at the tip of any needle providing clinician guidance to improve clinical outcomes, lower costs and increase patient satisfaction.
Within the TMCx program, the selected medical device startups will receive a comprehensive and practical curriculum to assist participating founders on their entrepreneurial path. Successful investors, entrepreneurs, subject-matter experts, industry professionals and hospital leaders guide each startup in the areas of intellectual property, product development, regulatory strategies, health policy, marketing, fundraising, contract negotiations and communications. In addition, TMCx companies participate in the accelerator without the requirement to provide equity in return.
The graduating companies from the program will give their final pitch in front of advisors, hospital stakeholders and investors as part of Demo Day at the end of the curriculum on Nov. 17, 2016.
Applications for the fourth TMCx class, focused on digital health, will be accepted beginning August 17. The class will run from early 2017 until June 2017. For more information, visit the TMC Innovation Institute.